Yeung CM, Suhardi VJ, Varady NH, et al. - This study was undertaken to investigate trends of prosthetic joint infection organisms and recurrence for a single high-volume arthroplasty surgeon over 20 years. Between 1995-2018, researchers retrospectively assessed all consecutive total joint arthroplasty (TJA) patients treated for prosthetic joint infection (PJI) by a single high-volume revision TJA surgeon. They evaluated microbial identities, antibiotic resistance, prior PJI, and musculoskeletal infectious disease (MSK ID) consultation. They treated 261 PJI patients (median age 66 years [interquartile range 57-75]). Minimal variations were reported in microbial/antibiotic resistances for PJI over 20 years in a single institution, implying current standards of PJI treatment remain encouragingly valid in most cases. There was no correlation between MSK ID involvement and lower reinfection risk overall; nevertheless, the risk of reinfection seemed to be somewhat lower with MSK ID involvement in individuals with prior PJI.